AYTU BIOPHARMA, INC Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aytu Biopharma, Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Aytu Biopharma, Inc Entity Common Stock, Shares Outstanding for the quarter ending September 16, 2024 was 6.15M shares, a 11.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 6.15M +619K +11.2% Sep 16, 2024 10-K 2024-09-26
Q1 2024 5.57M +1.79M +47.3% May 1, 2024 10-Q 2024-05-15
Q4 2023 5.57M +1.99M +55.8% Feb 1, 2024 10-Q 2024-02-14
Q3 2023 5.53M -56.9M -91.1% Sep 20, 2023 10-K 2023-10-12
Q1 2023 3.78M -34.8M -90.2% May 8, 2023 10-Q 2023-05-11
Q4 2022 3.57M -26.7M -88.2% Feb 14, 2023 10-Q 2023-02-21
Q3 2022 62.4M +34.9M +127% Sep 19, 2022 10-K 2022-09-27
Q1 2022 38.6M +13.4M +53.3% May 9, 2022 10-Q 2022-05-16
Q4 2021 30.3M +12.4M +69.5% Feb 7, 2022 10-Q 2022-02-14
Q3 2021 27.6M -98.3M -78.1% Sep 10, 2021 10-K/A 2022-02-22
Q1 2021 25.2M -95.1M -79.1% May 10, 2021 10-Q 2021-05-17
Q4 2020 17.9M -5.14M -22.3% Feb 1, 2021 10-Q 2021-02-11
Q3 2020 126M +108M +611% Sep 15, 2020 10-K 2020-10-06
Q1 2020 120M +104M +622% May 1, 2020 10-Q 2020-05-15
Q4 2019 23M +12.5M +119% Feb 1, 2020 10-Q 2020-02-14
Q3 2019 17.7M +15.9M +882% Aug 31, 2019 10-K 2019-09-26
Q1 2019 16.7M -19.2M -53.6% May 1, 2019 10-Q 2019-05-14
Q4 2018 10.5M +5.52M +111% Feb 6, 2019 10-Q/A 2019-05-14
Q3 2018 1.8M -2.6M -59.1% Aug 31, 2018 10-K 2018-09-06
Q1 2018 35.9M +22.1M +159% May 1, 2018 10-Q 2018-05-14
Q4 2017 4.97M -5.88M -54.2% Feb 1, 2018 10-Q 2018-02-08
Q3 2017 4.4M -6.44M -59.4% Nov 1, 2017 10-Q 2017-11-09
Q1 2017 13.8M -31M -69.2% May 1, 2017 10-Q 2017-05-11
Q4 2016 10.8M -3.72M -25.5% Feb 1, 2017 10-Q 2017-02-09
Q3 2016 10.8M -3.41M -23.9% Nov 3, 2016 10-Q 2016-11-07
Q1 2016 44.9M +25.4M +131% May 6, 2016 10-Q 2016-05-11
Q4 2015 14.6M +8.73M +150% Feb 1, 2016 10-Q 2016-02-11
Q3 2015 14.3M Sep 1, 2015 10-K 2015-09-30
Q1 2015 19.4M +14.5M +295% Mar 15, 2015 10-Q 2015-04-15
Q4 2014 5.84M +918K +18.7% Jan 12, 2015 10-Q 2015-01-12
Q2 2014 5.74M +846K +17.3% Jul 1, 2014 10-Q 2014-07-10
Q1 2014 4.92M +28K +0.57% Apr 11, 2014 10-Q 2014-04-11
Q4 2013 4.92M +28K +0.57% Jan 10, 2014 10-Q 2014-01-10
Q2 2013 4.89M +33.3K +0.69% Jun 30, 2013 10-Q 2013-06-28
Q1 2013 4.89M +64.8K +1.34% Mar 31, 2013 10-Q 2013-04-15
Q4 2012 4.89M +115K +2.41% Jan 10, 2013 10-Q 2013-01-14
Q2 2012 4.86M Jun 15, 2012 10-Q 2012-06-26
Q1 2012 4.82M Apr 5, 2012 10-Q 2012-04-12
Q4 2011 4.77M Dec 23, 2011 10-Q 2011-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.